Table 2.
Control Male | Control Female | Caffeine Male | Caffeine Female | |
---|---|---|---|---|
(n=7) | (n=8) | (n=8) | (n=8) | |
Place Learning Path Length (cm) |
||||
Day 1 | 2182 ± 182 | 2571 ± 257 | 2732 ± 161 | 2125 ± 186 |
Day 2 | 1524 ± 181 | 1252 ± 189 | 1360 ± 247 | 1320 ± 167 |
Day 3 | 770 ± 156 | 1232 ± 268 | 1171 ± 205 | 890 ± 224 |
Reversal Path Length (cm) | ||||
Day 4 | 1449 ± 249 | 2249 ± 408 | 1911 ± 255 | 1613 ± 325 |
Day 5 | 1264 ± 227 | 1884 ± 245 | 1927 ± 279 | 1327 ± 326 |
Day 6 | 968 ± 237 | 1188 ± 198 | 737 ± 91 | 1148 ± 175 |
Working Memory Path Length (cm) | ||||
Day 7 - Trial 1 | 2753 ± 973 | 2318 ± 636 | 2026 ± 744 | 1658 ± 403 |
Day 7 - Trial 2 | 930 ± 372 | 1722 ± 603 | 1269 ± 296 | 1023 ± 395 |
Day 7 - Trial 3 | 854 ± 219 | 788 ± 300 | 548 ± 129 | 1233 ± 475 |
Day 7 - Trial 4 | 591 ± 290 | 583 ± 193 | 473 ± 130 | 713 ± 303 |
Day 8 - Trial 1 | 3192 ± 597 | 2905 ± 975 | 3802 ± 762 | 3639 ± 812 |
Day 8 - Trial 2 | 1247 ± 202 | 1549 ± 443 | 2886 ± 809 | 729 ± 125 |
Day 8 - Trial 3 | 1310 ± 318 | 1102 ± 266 | 1839 ± 196 | 1114 ± 308 |
Day 8 - Trial 4 | 1647 ± 401 | 944 ± 221 | 841 ± 75 | 814 ± 191 |
Day 9 - Trial 1 | 1684 ± 273 | 3650 ± 734 | 2301 ± 604 | 2115 ± 537 |
Day 9 - Trial 2 | 814 ± 180 | 1069 ± 349 | 1553 ± 399 | 1338 ± 525 |
Day 9 - Trial 3 | 1083 ± 457 | 1352 ± 369 | 777 ± 297 | 1029 ± 199 |
Day 9 - Trial 4 | 1117 ± 391 | 798 ± 137 | 869 ± 358 | 544 ± 100 |